# A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors

> **NCT01494688** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 217 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** RO5509554

## Key facts

- **NCT ID:** NCT01494688
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-20
- **Primary completion:** 2018-02-07
- **Final completion:** 2018-02-07
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2018-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494688, "A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01494688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*